Keywords: news, brief, labeling, merck, co, hmg-coa, reductase

News In Brief

Article | 07 November 1997

Print This

- Labeling for Merck & Co's HMG-CoA reductase inhibitor Zocor(simvastatin) has been expanded in the USA to include the lowering of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in